venBio Select Advisor »

Vera Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $227M 5.3M 43.12

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common (ALPN)

View all positions for venBio Select Advisor

Top funds holding Vera Therapeutics

venBio Select Advisor
BlackRock
Commodore Capital
FMR
Sofinnova Ventures
T. Rowe Price Associates
State Street Corporation
Vanguard Group
Eversept Partners
Morgan Stanley
Kynam Capital Management
Holocene Advisors
Point72 Asset Management
Pictet Asset Management Holding SA
Geode Capital Management

View all funds holding Vera Therapeutics